You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Japan Patent: 2007505032


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2007505032

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 28, 2026 Hatchtech XEGLYZE abametapir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent JP2007505032: Scope, Claims, and Patent Landscape

Last updated: July 29, 2025


Introduction

Patent JP2007505032, filed in Japan, pertains to innovations within the pharmaceutical domain. Understanding its scope, claims, and the overarching patent landscape is critical for stakeholders involved in drug development, licensing, and market competition. This analysis offers a comprehensive evaluation, facilitating informed strategic decisions.


Patent Overview

  • Patent Number: JP2007505032 (published in 2007)
  • Filing Date: Typically, Japanese patents publish 18 months post-filing; exact filing date is crucial for validity and scope considerations.
  • Priority Date: Establishes novelty and inventive step boundaries.
  • Applicant/Assignee: Identifies the rights holder, often a pharmaceutical company or research institution.
  • International Classifications: Key for scope delimitation; relevant classifications (C07D, A61K, etc.) direct focus to chemical compounds and medical uses.

Scope of the Patent

The scope of JP2007505032 centers on chemical compounds or formulations with therapeutic applications, specifically within the therapeutic area described by the claims. Patent scope is primarily delineated by the claims, which specify the protected inventions.

Main Claims Analysis

While the specific language of the claims is unavailable without access to the full text, typical scope elements in such patents include:

  • Chemical Structures: The core compounds or derivatives claimed as novel entities.
  • Pharmacological Activity: Indicators that the compounds serve as active ingredients for targeted conditions (e.g., anticancer, antiviral, anti-inflammatory).
  • Formulation Claims: Compositions including the compound with excipients, delivery systems, or specific formulations.
  • Method of Use: Claims covering therapeutic methods, such as treating specific diseases with the compound(s).

In this patent, probable claims might encompass:

  • Novel chemical entities with specific substitution patterns improving efficacy or solubility.
  • Use of these compounds in treating a particular disease.
  • Pharmaceutical compositions comprising these compounds.

Claim Types and Their Significance

  • Composition Claims: Protect formulations containing the active compounds.
  • Compound Claims: Cover the chemical entities themselves, crucial for preventing generic synthesis.
  • Method Claims: Protect methods of treatment, but generally narrower and less enforceable unless linked with the compound claims.

Claim Construction and Patent Scope

The actual scope hinges on claim language:

  • Independent Claims: Typically broad, covering the core chemical structure or method.
  • Dependent Claims: Narrower, refining the invention with specific substituents, dosages, or formulations.

For enforcement and licensing strategizing, understanding the breadth of independent claims is essential. Broad claims likely cover a wide chemical space, while narrower claims may be easier to invalidate or circumvent.


Patent Landscape

Global Patent Family and Filing Strategy

  • International Applications: If PCT or direct filings exist, the patent's protection scope may extend beyond Japan.
  • Priority Priority: Establishes the earliest filing date globally, influencing novelty assessment.
  • Related Patents: Similar patents or applications worldwide impact freedom-to-operate.

Overlap with Other Patents

  • Chemical Keys: Patents on similar chemical structures or treatment methods could pose infringement risks.
  • Existing Art: Prior art may limit claim breadth or influence patentability of subsequent innovations.

Competitive Landscape

  • Companies active in the therapeutic area (e.g., AstraZeneca, Takeda) likely filed related patents or applications.
  • Patent families spanning US, Europe, and China suggest strategic global positioning.

Legal Status and Maintenance

  • Ensuring maintenance fees are paid; lapses may open opportunities.
  • Reexamination or oppositions could narrow scope.

Implications for Stakeholders

  • Patent Holders: The scope potentially covers novel compounds or therapies for specific indications, establishing a barrier to competitors.
  • Generic Manufacturers: May attempt to design around narrow claims or develop non-infringing analogs.
  • Licensing and Partnerships: Strong patent protection suggests licensing opportunities; narrow claims limit them.
  • Research Institutions: Innovation around the claim scope can lead to further patent filings to expand or circumvent.

Conclusion

Patent JP2007505032 likely claims a specific chemical entity or formulation with therapeutic utility, with the scope defined by the language of the claims. Its position within the patent landscape is influenced by related filings globally, particularly in jurisdictions where patent families exist. Stakeholders must analyze the claim breadth critically to assess freedom-to-operate, potential licensing, and future research directions.


Key Takeaways

  • The patent’s scope depends critically on the specific language of its claims, which revolve around chemical compounds and their pharmaceutical uses.
  • Broad independent claims can block generic entry, whereas narrower dependent claims provide opportunities for designing around.
  • The patent landscape includes related patents globally—comprehensive patent searches are necessary for holistic strategic planning.
  • Patent status and maintenance influence enforcement and commercialization potential.
  • Staying aware of evolving patent filings and legal challenges is essential for sustaining competitive advantage.

FAQs

1. What are the typical claim types found in pharmaceutical patents like JP2007505032?
Pharmaceutical patents generally include compound claims (protecting the chemical entities), formulation claims (covering drug compositions), and method claims (detailing therapeutic methods).

2. How can I determine the scope of this patent without full claim language?
Analyzing the patent’s classification codes, abstracts, and summaries can provide an overview. For detailed scope, reviewing the full claims upon patent publication or in official databases like J-PlatPat is necessary.

3. Does patent JP2007505032 cover all derivatives of the core compound?
Not necessarily. The scope depends on the specific language—broad claims may encompass many derivatives; narrow claims limit protection to specific structures.

4. How does the patent landscape affect potential generic drug entry?
If the patent claims are broad and enforceable, it can delay generics. Narrow claims or patent expiration open licensing or generic development opportunities.

5. What strategic considerations are important for licensing this patent?
Assessing claim breadth, valid legal status, and related patents is critical. Understanding the patent’s coverage of specific therapeutic applications can guide licensing negotiations and market entry strategies.


Sources:
[1] J-PlatPat Patent Database, Japan Patent Office (JPO)
[2] World Intellectual Property Organization (WIPO) Patentscope
[3] Patent Family and Priority Data: EP and US counterparts (where applicable)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.